Digital Health Briefs: Stage 3 Meaningful Use; Proteus Digital Health; Google Glass
This article was originally published in The Gray Sheet
ONC advisory committee approves meaningful use stage 3 recommendations. EU hints at mHealth process progress. Proteus Digital Health Inc. signals expansion to England. More digital health briefs.
You may also be interested in...
Last year, Mallinckrodt attempted restructuring the firm to evade bankruptcy fears. However, the company is now filing for bankruptcy for its US generics business to address “unmanageable liabilities.”
Informa Pharma Intelligence has officially launched the seventh Global Generics & Biosimilars Awards, which will take place in October 2020 in Milan, Italy.
Hours before the US FDA confirmed the first drug shortage due to active pharmaceutical ingredient constraints because of the coronavirus situation in China, generics industry leader Mylan came under pressure about the potential impact on its business.